News and Resources
News and resources
Statement by Julian Lob-Levyt, GAVI Alliance Executive Secretary at the conference on Innovative Financing for Development
GAVI commends France and the UK for their work in developing innovative ways to finance achieving the Millennium Development Goals. In particular, GAVI welcomes their decision to support the International Financing Facility for Immunization, which will save millions of children by giving them access to vaccines and improving health systems in devel...
IFFIm takes next steps toward saving millions of lives
The International Finance Facility for Immunization (IFFIm), the new multinational fund that will leverage long-term commitments from rich governments to raise urgently needed financing for health programmes in poor countries, is close to implementation, the GAVI Alliance announced today.
Norway increases and prolongs support for global immunisation until 2015
The Prime Minister of Norway, Jens Stoltenberg, announced today that starting in 2006 the Government of Norway will boost its annual support to the GAVI Alliance (formerly known as the Global Alliance for Vaccines and Immunization).
Key European Nations join UK and France to commit nearly US$4 billion to expand child immunisation in developing countries
Innovative financing approach will tap capital markets to maximize impact of funds London, 9 September - The United Kingdom, France, Italy, Spain, and Sweden today committed nearly US$4 billion to support and scale up the work of the Global Alliance for Vaccines and Immunisation (GAVI) over the next decade. These long-term and unprecedented financ...
Statement regarding IFFIm and Eurostat ruling
The Eurostat decision paves the way for the full-funding and eventual implementation of IFFIm. We are delighted by this decision and are grateful to all those who worked so hard to create this innovative financing vehicle.
Hilary Benn pledges £1 billion to boost health care in developing countries
Hilary Benn the Secretary of State for International Development (DFID) today announced that the UK will pledge almost £1 billion (US$1.8 billion) over 15 years to help immunise children and adults in the world’s poorest countries.
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.